Severe Hyperkalemia Treatment Guidelines
Immediate Emergency Management (Serum K⁺ ≥6.5 mEq/L or ECG Changes)
For severe hyperkalemia (≥6.5 mEq/L) or any ECG changes, immediate multi-pronged emergency treatment is required to prevent fatal cardiac arrhythmias, even in asymptomatic patients. 1, 2, 3
Step 1: Cardiac Membrane Stabilization (First Priority – Within 1-3 Minutes)
- Administer IV calcium immediately to protect against arrhythmias; this is the only intervention that works within 1-3 minutes 1, 2
- Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes (preferred for peripheral access) 1, 2
- OR calcium chloride 10%: 5-10 mL IV over 2-5 minutes (more potent, requires central access) 1, 2
- Repeat the calcium dose if no ECG improvement within 5-10 minutes 1, 2
- Critical caveat: Calcium does NOT lower potassium—it only temporarily stabilizes cardiac membranes for 30-60 minutes 1, 2
- Never delay calcium while waiting for repeat lab confirmation if ECG changes are present 1, 2
Step 2: Shift Potassium Intracellularly (Administer All Three Simultaneously)
Give all three agents together for maximum effect within 15-60 minutes: 1, 2
Insulin + Glucose (Most Reliable)
- Insulin 10 units regular IV push + 25g dextrose (50 mL D50W) 1, 2
- Lowers K⁺ by 0.5-1.2 mEq/L within 30-60 minutes, lasting 4-6 hours 1, 2
- Never give insulin without glucose—hypoglycemia can be fatal 1, 2
- Monitor blood glucose closely; patients with low baseline glucose, no diabetes, female sex, or renal impairment are at higher hypoglycemia risk 1
Nebulized Albuterol (Adjunctive)
- Albuterol 10-20 mg in 4 mL nebulized over 10-15 minutes 1, 2
- Lowers K⁺ by 0.5-1.0 mEq/L within 30 minutes, lasting 2-4 hours 1, 2
- Can be repeated every 2 hours if needed 1, 2
- Combined insulin-glucose plus albuterol is more effective than either alone 1, 2
Sodium Bicarbonate (ONLY with Metabolic Acidosis)
- Sodium bicarbonate 50 mEq IV over 5 minutes ONLY if pH <7.35 and bicarbonate <22 mEq/L 1, 2
- Onset 30-60 minutes; ineffective without documented acidosis 1, 2
- Do NOT use without metabolic acidosis—it wastes time 1, 2
Step 3: Remove Potassium from the Body (Definitive Treatment)
Loop Diuretics (If Adequate Renal Function)
- Furosemide 40-80 mg IV for patients with eGFR >30 mL/min and adequate urine output 1, 2
- Only effective with preserved kidney function 1, 2
Hemodialysis (Most Reliable Method)
Hemodialysis is the gold standard for severe hyperkalemia and should be initiated urgently for: 1, 2, 3
- K⁺ >6.5 mEq/L unresponsive to medical therapy 1, 2
- Oliguria or anuria 1, 2
- End-stage renal disease 1, 2
- Ongoing potassium release (tumor lysis syndrome, rhabdomyolysis) 1, 2
- Severe renal impairment (eGFR <15 mL/min) 1, 2
- Persistent ECG changes despite medical management 1, 2
In hemodynamically unstable patients (hypotension, vasopressor requirement), continuous renal replacement therapy (CRRT) is preferred over intermittent hemodialysis to minimize rapid fluid shifts 1
Potassium Binders (Sub-acute Management)
- Sodium zirconium cyclosilicate (SZC/Lokelma): 10g three times daily for 48 hours, then 5-15g once daily 1, 2
- Patiromer (Veltassa): 8.4g once daily, titrated up to 25.2g daily 1, 2
- Avoid sodium polystyrene sulfonate (Kayexalate) due to risk of bowel necrosis, colonic ischemia, and lack of efficacy data 1, 2
Medication Management During Acute Episode
Medications to Hold Immediately (When K⁺ >6.5 mEq/L)
- RAAS inhibitors (ACE inhibitors, ARBs, mineralocorticoid receptor antagonists) 1, 2
- NSAIDs 1, 2
- Potassium-sparing diuretics 1, 2
- Trimethoprim-containing agents 1, 2
- Heparin 1, 2
- Beta-blockers 1, 2
- Potassium supplements and salt substitutes 1, 2
After Acute Resolution: Preventing Recurrence
- Restart RAAS inhibitors at a lower dose once K⁺ <5.0 mEq/L 1, 2
- Initiate a potassium binder (SZC or patiromer) to enable continuation of life-saving RAAS therapy 1, 2
- Do NOT permanently discontinue RAAS inhibitors—they provide mortality benefit in cardiovascular and renal disease 1, 2
Monitoring Protocol
Acute Phase
- Recheck K⁺ within 1-2 hours after insulin/glucose or albuterol therapy 1, 2
- Continue K⁺ checks every 2-4 hours until stable 1, 2
- Obtain repeat ECG to confirm resolution of cardiac changes 1, 2
- Monitor for rebound hyperkalemia 2-4 hours post-treatment, as intracellular K⁺ redistributes 1, 2
Post-Acute Phase
- Check K⁺ within 1 week after initiating or escalating RAAS inhibitors 1, 2
- Reassess 7-10 days after starting a potassium binder 1, 2
- Individualize monitoring frequency based on eGFR, heart failure, diabetes, or prior hyperkalemia episodes 1, 2
Critical Pitfalls to Avoid
- Do NOT delay calcium administration while awaiting repeat K⁺ levels when ECG changes are present—ECG changes indicate urgent need regardless of exact K⁺ value 1, 2
- Never give insulin without glucose—hypoglycemia can be fatal 1, 2
- Recognize that calcium, insulin, and beta-agonists are temporizing measures only—they do NOT remove K⁺ from the body 1, 2
- Do NOT use sodium bicarbonate without documented metabolic acidosis—it is ineffective and wastes time 1, 2
- Do NOT permanently discontinue RAAS inhibitors—use potassium binders to maintain these life-saving medications 1, 2
- Do NOT rely solely on ECG findings—they are highly variable and less sensitive than laboratory tests 1, 2
- Remember that failure to initiate concurrent K⁺-removal therapies will result in recurrent life-threatening arrhythmias within 30-60 minutes after temporizing measures wear off 1, 2
Special Considerations
Tumor Lysis Syndrome
- In tumor lysis syndrome with elevated phosphate, use calcium cautiously as it increases risk of calcium-phosphate precipitation in tissues 1
- Never administer calcium through the same IV line as sodium bicarbonate—precipitation will occur 1
Malignant Hyperthermia
- In patients with malignant hyperthermia and hyperkalemia, calcium should only be used in extremis as it may contribute to calcium overload of the myoplasm 1